Stock KYKOY KYOWA KIRIN CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Kyowa Kirin Co., Ltd. OTC Markets

Equities

KYKOY

US50156R1077

Pharmaceuticals

Delayed OTC Markets
Other stock markets
 14:50:18 16/07/2024 BST 		5-day change 1st Jan Change
19.85 USD +0.27% Intraday chart for Kyowa Kirin Co., Ltd. 0.00% +22.18%
07-03 Kyowa Kirin Buys Back Shares MT
07-02 Tranche Update on Kyowa Kirin Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024. CI

Business Summary

Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:

- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;

- sales of licenses (7.4%).

At the end of 2021, the group had 3 production sites located in Japan (2) and China.

Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).

Number of employees: 5,974

Sales per Business

JPY in Million2022Weight2023Weight Delta
Manufactured Product
90.5 %
364,596 91.5 % 400,372 90.5 % +9.81%
Technology
9.5 %
33,775 8.5 % 41,860 9.5 % +23.94%

Sales per region

JPY in Million2022Weight2023Weight Delta
United States
38.9 %
139,852 35.1 % 172,242 38.9 % +23.16%
Japan
34.7 %
154,636 38.8 % 153,462 34.7 % -0.76%
Europe
14.9 %
62,251 15.6 % 65,745 14.9 % +5.61%
Asia
10.1 %
37,368 9.4 % 44,759 10.1 % +19.78%
Americas
1.1 %
4,053 1.0 % 5,054 1.1 % +24.70%
Other
0.2 %
210 0.1 % 972 0.2 % +362.86%

Managers

Managers TitleAgeSince
Motohiko Kawaguchi DFI
 Director of Finance/CFO - 31/03/86
Masashi Miyamoto PSD
 President 65 31/03/85
Takeyoshi Yamashita CTO
 Chief Tech/Sci/R&D Officer 62 31/03/10
Yoshifumi Torii CTO
 Chief Tech/Sci/R&D Officer 57 31/03/94
Yutaka Osawa CMP
 Compliance Officer 64 31/03/84
Takuo Hirose CTO
 Chief Tech/Sci/R&D Officer 53 30/09/18
Toshifumi Mikayama BRD
 Director/Board Member 67 30/09/08
Keiji Kuwata AUD
 Comptroller/Controller/Auditor 61 28/02/19
Hiroshi Komatsu AUD
 Comptroller/Controller/Auditor 61 31/03/12
Wataru Murata HRO
 Human Resources Officer - 31/03/83

Members of the board

Members of the board TitleAgeSince
Takashi Oyamada BRD
 Director/Board Member 68 28/02/21
Yoshihisa Suzuki BRD
 Director/Board Member 69 28/02/22
Toshifumi Mikayama BRD
 Director/Board Member 67 30/09/08
Jun Arai BRD
 Director/Board Member 65 28/02/21
Masashi Miyamoto PSD
 President 65 31/03/85
Yutaka Osawa CMP
 Compliance Officer 64 31/03/84
Takeshi Minakata BRD
 Director/Board Member 62 29/03/22
Akira Morita BRD
 Director/Board Member 73 28/02/19
Yuko Haga BRD
 Director/Board Member 68 28/02/19
Rumiko Nakata BRD
 Director/Board Member 68 28/02/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 540,000,000 245,225,886 ( 45.41 %) 4,955,614 ( 0.9177 %) 45.41 %

Shareholders

NameEquities%Valuation
KIRIN HOLDINGS COMPANY, LIMITED
53.49 %
288,819,000 53.49 % 4 933 M $
KYOWA KIRIN CO. LTD.
2.273 %
12,275,511 2.273 % 210 M $
Goldman Sachs Asset Management Co., Ltd. (Japan)
0.9664 %
5,218,699 0.9664 % 89 M $
DAI-ICHI LIFE HOLDINGS, INC.
0.5407 %
2,920,000 0.5407 % 50 M $
Boston Common Asset Management LLC
0.2017 %
1,088,995 0.2017 % 19 M $
Kewpie Pension Fund
0.0880 %
475,000 0.0880 % 8 M $
State Street Global Advisors Ltd.
0.0822 %
443,638 0.0822 % 8 M $
Sumitomo Mitsui Trust Asset Management Co., Ltd.
0.0670 %
361,700 0.0670 % 6 M $
SHOWA SANGYO CO., LTD.
0.0639 %
345,000 0.0639 % 6 M $
SUZUKEN CO., LTD.
0.0631 %
341,000 0.0631 % 6 M $

Holdings

NameEquities%Valuation
KYOWA KIRIN CO. LTD.
2.27%
 12,275,511 2.27% 209,666,587 $
ARDELYX, INC.
1.23%
 2,873,563 1.23% 21,293,102 $
HOKUYAKU TAKEYAMA HOLDINGS,INC.
0.21%
 52,000 0.21% 278,329 $

Company contact information

Kyowa Kirin Co., Ltd.

Otemachi Financial City Grand Cube 1-9-2 Otemachi

100-0004, Tokyo

+81 3 5205 7200

http://www.kyowa-kirin.co.jp
address Kyowa Kirin Co., Ltd.(KYKOY)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Sales per region

Ratings for Kyowa Kirin Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
3,107 JPY
Average target price
3,095 JPY
Spread / Average Target
-0.37%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
MERCK KGAA Stock Merck KGaA
+7.01% 72.01B
YUHAN CORPORATION Stock Yuhan Corporation
+40.84% 5.26B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-18.53% 4.64B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+12.65% 3.7B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+27.58% 2.3B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-39.96% 1.8B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-45.87% 1.7B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
-0.41% 1.58B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4151 Stock
  4. KYKOY Stock
  5. Company Kyowa Kirin Co., Ltd.